Feed aggregator

Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission

Biospace news - Tue, 03/19/2024 - 02:00
Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission 3/19/2024

Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease

Biospace news - Tue, 03/19/2024 - 02:00
Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease 3/19/2024

Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch

Biospace news - Tue, 03/19/2024 - 02:00
Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch 3/19/2024

Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis

Biospace news - Tue, 03/19/2024 - 02:00
Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis 3/19/2024

Report: 2024 U.S. Life Sciences Salary Trends

Biospace news - Tue, 03/19/2024 - 02:00
Report: 2024 U.S. Life Sciences Salary Trends 3/19/2024

Bacteria commonly found in the body contribute to stomach cancer

World Pharma News - Mon, 03/18/2024 - 11:00
A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the world.

Streptococcus anginosus bacteria exist alongside other germs in the mouth, throat, intestines and vagina. Occasionally, they may cause mild infections like sore throats and skin infections.

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need

Biospace news - Mon, 03/18/2024 - 02:00
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need 3/18/2024

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data

Biospace news - Mon, 03/18/2024 - 02:00
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data 3/18/2024

J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline

Biospace news - Mon, 03/18/2024 - 02:00
J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline 3/18/2024

Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon

Biospace news - Mon, 03/18/2024 - 02:00
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon 3/18/2024

AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer

Biospace news - Mon, 03/18/2024 - 02:00
AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer 3/18/2024

Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies

Biospace news - Mon, 03/18/2024 - 02:00
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies 3/18/2024

FDA Action Alert: Orchard, ITF, Merck and More

Biospace news - Mon, 03/18/2024 - 02:00
FDA Action Alert: Orchard, ITF, Merck and More 3/18/2024

Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now?

Biospace news - Mon, 03/18/2024 - 02:00
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now? 3/18/2024

Bayer and Aignostics to collaborate on next generation precision oncology

World Pharma News - Fri, 03/15/2024 - 11:00
Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world's leading hospitals, Charité-Universitätsmedizin Berlin, and a global leader in using computational pathology to transform complex biomedical data into biology insights.

FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma

Biospace news - Fri, 03/15/2024 - 02:00
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma 3/15/2024

Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data

Biospace news - Fri, 03/15/2024 - 02:00
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data 3/15/2024

Biotheus, Hansoh Expand Partnership in $694M ADC Deal

Biospace news - Fri, 03/15/2024 - 02:00
Biotheus, Hansoh Expand Partnership in $694M ADC Deal 3/15/2024

Astellas Backs Out of Potential $340M Licensing Deal with Cartesian

Biospace news - Fri, 03/15/2024 - 02:00
Astellas Backs Out of Potential $340M Licensing Deal with Cartesian 3/15/2024

Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets

Biospace news - Fri, 03/15/2024 - 02:00
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets 3/15/2024